Gastric cancer associated with acute disseminated intravascular coagulation: successful initial treatment with weekly 24‐hour infusion of high‐dose 5‐fluorouracil and leucovorin

Acute disseminated intravascular coagulation (DIC) is a severe complication of gastric adenocarcinoma, and most of the patients die within 1–3 weeks. We have treated five such patients with an empirical non‐ myelosuppressive HDFL regimen (weekly 24 h infusion of high‐dose 5‐fluorouracil 2600 mg/m2 and leucovorin 300 mg/m2). Within 2 weeks of starting the treatment the clinical and laboratory evidence of acute DIC quickly resolved in all five patients. HDFL not only caused no further myelosuppression, but also resulted in normalization of the patient's haemogram within a few weeks. Other anti‐cancer drugs could then be safely added. Three patients had a survival time of more than 6 months. We suggest that HDFL is an ideal initial treatment for gastric cancer complicated by acute DIC.

[1]  T. van der Poll,et al.  Disseminated Intravascular Coagulation , 1999, Thrombosis and Haemostasis.

[2]  Ming-Tseh Lin,et al.  A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers. , 1997, Anticancer research.

[3]  K. Yeh,et al.  Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers. An effective and low-toxic regimen for patients with poor general condition. , 1997, Oncology.

[4]  K. Yeh,et al.  High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy. , 1997, British Journal of Cancer.

[5]  F. Monti,et al.  Acute disseminated intravascular coagulation syndrome in cancer patients. , 1995, Oncology.

[6]  P. Vincent,et al.  Blood — Principles and Practice of Hematology , 1995 .

[7]  K. Yeh,et al.  An alternative method to overcome central venous portable external infusion pump blockage in patients receiving weekly 24-hour high-dose fluorouracil and leucovorin. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  E. Tian,et al.  A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  R. Colman,et al.  Disseminated intravascular coagulation due to malignancy. , 1990, Seminars in oncology.

[10]  M. Tuchman,et al.  Familial pyrimidinemia and pyrimidinuria associated with severe fluorouracil toxicity. , 1985, The New England journal of medicine.

[11]  V. Vaitkevicius,et al.  Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion. , 1980, Cancer research.

[12]  W. Fung,et al.  Fulminant disseminated intravascular coagulation in advanced gastric carcinoma. , 1979, The American journal of gastroenterology.